{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/62d20dbcffef490011c8df4b/62ee28218a993e00125843ac?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"4. Metastatic Non-Small Cell Lung Cancer","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/62d20dbcffef490011c8df4b/1687409634073-3f253f226e9d9dde2135cda3c3fe8c82.jpeg?height=200","description":"<p>Four episodes already! How time flies when you're having fun. In this episode, Josh and Michael discuss metastatic lung cancer, an area of oncology where a survival benefit of a few months generates cheers, tears and standing ovations. So what happens when studies start to improve patients' outcomes by YEARS? I don't know, but there were almost certainly minds that were thoroughly blown. Join us for this most optimistic of episodes!</p><p><br></p><p>Links to papers discussed in this episode (subscription may be required):</p><p>KEYNOTE-189: <a href=\"https://www.nejm.org/doi/full/10.1056/nejmoa1801005\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.nejm.org/doi/full/10.1056/nejmoa1801005</a></p><p>FLAURA: <a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1913662\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.nejm.org/doi/full/10.1056/NEJMoa1913662</a></p><p><br></p><p>For more episodes, resources and blog posts, visit <strong>inquisitiveonc.com</strong></p><p>Find us on Twitter <strong>@InquisitiveOnc!</strong></p><p>If you want us to look at a specific trial or subject, email us at<strong> inquisitiveonc@gmail.com</strong></p><p><br></p><p>Art courtesy of Taryn Silver</p><p>Music courtesy of AlexiAction: https://pixabay.com/users/alexiaction-26977400/</p><p><br></p><p><strong>Disclaimer:</strong> This podcast is for educational purposes only. If you are unwell, seek medical advice.</p>","author_name":"Michael Fernando and Josh Hurwitz"}